Skip to main content
European Commission logo print header

Leveraging Pharmaceutical Sciences and Structural Biology Training to develop 21st Century Vaccines

Rezultaty

Identification of Rabies antigen for alternative vaccination routes

Identification of RSV antigen for alternative vaccination routes

Immunological properties of the modified GBS antigen
Bio-distribution of lipid nanoparticles
Identification of self-amplifying Rabies RNA construct

Identification of self-amplifying RSV RNA construct

Optimised adjuvant system for GBS antigen presentation
Optimised adjuvant system for a Rabies vaccine

Optimised adjuvant system for an RSV vaccine

Model to investigate intracellular ROS, antigen presentation and specific T cell responses
Evaluating polymeric particles, cationic emulsions and lipoplex formulations
Bio-distribution of adjuvants and associated antigens–mucosal routes
Metabolic factors that contribute to the impaired adaptive immunity in older adults
Key physico-chemical attributes of alum, emulsion, liposome and nanoparticle systems shown to be effective as adjuvants
Bio-distribution of adjuvants and their associated antigen - 1
Comparing the immune response efficacy of antigen and adjuvant combinations - mucosal routes
Optimised adjuvant attributes for self-amplifying RNA vaccines
Bio-distribution of selected polymeric particles, cationic emulsions and lipoplexes
Evaluation of the immune response efficacy
Comparison of cellular uptake in monocyte-derived macrophages and dendritic cells
Structural flexibility of the MenB Antigen

Structural flexibility of the GBS Antigen

Impact of adjuvant design
Identification of T-cell epitopes
Modulation of T-cell epitope affinity
Key biophysical and physico-chemical attributes of current lipid nanoparticles
Bio-distribution of adjuvants and their associated antigen - 2
Adjuvant properties identified
Correlation of adjuvant properties (identified in WP2) with efficacy of immunisation
Interactions of GBS and Rabies antigen and adjuvants

Interactions of GBS and RSV antigen and adjuvants

Data management plan

Agreement and implementation of a data management plan.

Publikacje

Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection

Autorzy: Gustavo Lou, Giulia Anderluzzi, Signe Tandrup Schmidt, Stuart Woods, Simona Gallorini, Michela Brazzoli, Fabiola Giusti, Ilaria Ferlenghi, Russell Johnson, Craig W. Roberts, Derek T. O'Hagan, Barbara C. Baudner, Yvonne Perrie
Opublikowane w: Journal of Controlled Release, Numer Online ahead of print., 2020, Strona(/y) Online ahead of print., ISSN 0168-3659
Wydawca: Elsevier BV
DOI: 10.1016/j.jconrel.2020.06.027

Scalable Manufacturing Processes for Solid Lipid Nanoparticles

Autorzy: Giulia Anderluzzi, Gustavo Lou, Yang Su, Yvonne Perrie
Opublikowane w: Pharmaceutical Nanotechnology, Numer 7/6, 2019, Strona(/y) 444-459, ISSN 2211-7385
Wydawca: Bentham Science
DOI: 10.2174/2211738507666190925112942

Microfluidic Manufacture of Solid Lipid Nanoparticles: A Case Study on Tristearin-Based Systems.

Autorzy: Giulia Anderluzzi, Yvonne Perrie
Opublikowane w: Drug Delivery Letters, Numer 09, 2019, ISSN 2210-3031
Wydawca: Bentham Science
DOI: 10.2174/2210303109666190807104437

A novel microfluidic-based approach to formulate size-tuneable large unilamellar cationic liposomes: Formulation, cellular uptake and biodistribution investigations

Autorzy: Gustavo Lou, Giulia Anderluzzi, Stuart Woods, Craig W. Roberts, Yvonne Perrie
Opublikowane w: European Journal of Pharmaceutics and Biopharmaceutics, Numer 143, 2019, Strona(/y) 51-60, ISSN 0939-6411
Wydawca: Elsevier BV
DOI: 10.1016/j.ejpb.2019.08.013

Investigating the Impact of Delivery System Design on the Efficacy of Self-Amplifying RNA Vaccines

Autorzy: Giulia Anderluzzi, Gustavo Lou, Simona Gallorini, Michela Brazzoli, Russell Johnson, Derek T. O’Hagan, Barbara C. Baudner, Yvonne Perrie
Opublikowane w: Vaccines, Numer 8/2, 2020, Strona(/y) 212, ISSN 2076-393X
Wydawca: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/vaccines8020212

Using microfluidics for scalable manufacturing of nanomedicines from bench to GMP: A case study using protein-loaded liposomes

Autorzy: Cameron Webb, Neil Forbes, Carla B. Roces, Giulia Anderluzzi, Gustavo Lou, Suraj Abraham, Logan Ingalls, Keara Marshall, Timothy J. Leaver, Julie A. Watts, Jonathan W. Aylott, Yvonne Perrie
Opublikowane w: International Journal of Pharmaceutics, Numer 582, 2020, Strona(/y) 119266, ISSN 0378-5173
Wydawca: Elsevier BV
DOI: 10.1016/j.ijpharm.2020.119266

Mannosylation of LNP Results in Improved Potency for Self-Amplifying RNA (SAM) Vaccines

Autorzy: Roshan Goswami, Despo Chatzikleanthous, Gustavo Lou, Fabiola Giusti, Alessandra Bonci, Marianna Taccone, Michela Brazzoli, Simona Gallorini, Ilaria Ferlenghi, Francesco Berti, Derek T. O’Hagan, Carlo Pergola, Barbara C. Baudner, Roberto Adamo
Opublikowane w: ACS Infectious Diseases, Numer 5/9, 2019, Strona(/y) 1546-1558, ISSN 2373-8227
Wydawca: ACS
DOI: 10.1021/acsinfecdis.9b00084

Synthesis of protein conjugates adsorbed on cationic liposomes surface

Autorzy: Despo Chatzikleanthous, Robert Cunliffe, Filippo Carboni, Maria Rosaria Romano, Derek T. O'Hagan, Craig W. Roberts, Yvonne Perrie, Roberto Adamo
Opublikowane w: MethodsX, Numer 7, 2020, Strona(/y) 100942, ISSN 2215-0161
Wydawca: ELSEVIER
DOI: 10.1016/j.mex.2020.100942

Design of a novel vaccine nanotechnology-based delivery system comprising CpGODN-protein conjugate anchored to liposomes

Autorzy: Despo Chatzikleanthous, Signe Tandrup Schmidt, Giada Buffi, Ida Paciello, Robert Cunliffe, Filippo Carboni, Maria Rosaria Romano, Derek T. O'Hagan, Ugo D'Oro, Stuart Woods, Craig W. Roberts, Yvonne Perrie, Roberto Adamo
Opublikowane w: Journal of Controlled Release, Numer 323, 2020, Strona(/y) 125-137, ISSN 0168-3659
Wydawca: Elsevier BV
DOI: 10.1016/j.jconrel.2020.04.001

Wyszukiwanie danych OpenAIRE...

Podczas wyszukiwania danych OpenAIRE wystąpił błąd

Brak wyników